Abstract:Background Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is a multifunctional Ig-like cell adhesion molecule that has a wide range of biological functions. According to previous reports, serum CEACAM1 is dysregulated in different malignant tumours and associated with tumour progression. However, the serum CEACAM1 expression in non-small-cell lung carcinomas (NSCLC) is unclear. The different expression ratio of CEACAM1-S and CEACAM1-L isoform has seldom been investigated in NSCLC. This research is intended to study the serum CEACAM1 and the ratio of CEACAM1-S/L isoforms in NSCLC. Methods The expression of the serum CEACAM1 was determined by enzyme-linked immunosorbent assay. The protein expression and the location of CEACAM1 in tumours were observed by immunohistochemical staining. The CEACAM1 mRNA levels in tumour and normal adjacent tissues were measured using quantitative real-time PCR, and the expression patterns and the rate of CEACAM1-S and CEACAM1-L were analysed by reverse transcription-PCR. Results Serum CEACAM1 levels were significantly higher in NSCLC patients compared with that from normal healthy controls ( P <0.0001). 17 patients (81%) among 21 showed high expression of CEACAM1 by immunohistochemical staining. Although no significant differences were found between tumour and normal tissues on mRNA expression levels of CEACAM1 ( P >0.05), the CEACAM1-S and the CEACAM1-S/L (S: L) ratios were significantly higher in tumour than normal tissues ( P <0.05). Conclusions Our data indicated that the serum levels of CEACAM1 could discriminate lung cancer patients from health donors and that CEACAM1 might be a useful marker in early diagnosis of NSCLC. Moreover, our results showed that the expression patterns of CEACAM1 isoforms could be changed during oncogenesis, even when total CEACAM1 in tumour tissues did not show significant changes. Our study suggested that the expression ratios of CEACAM1-S/CEACAM1-L might be a better diagnostic indicator in NSCLC than the quantitative changes of CEACAM1.

Carcinoembryonic antigen‐related cell adhesion molecule 1 in cancer: Blessing or curse?

The CEA-/lo colorectal cancer cell population harbors cancer stem cells and metastatic cells.

Characteristics of Carcinoembryonic antigen related cell adhesion molecules and their relationship to cancer

Roles of CEACAM1 in cell communication and signaling of lung cancer and other diseases

Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAM) 1, 5 and 6 as Biomarkers in Pancreatic Cancer

The emerging roles of CEACAM6 in human cancer (Review)

Up-regulation of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Gastrointestinal Cancer and Its Clinical Relevance.

CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo

Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma

Inhibition of Cell Invasion and Migration by CEACAM1-4S in Breast Cancer.

Immunomodulatory roles of the carcinoembryonic antigen family of glycoproteins

CEACAM1 Cytoplastic Expression is Closely Related to Tumor Angiogenesis and Poorer Relapse-Free Survival after Curative Resection of Hepatocellular Carcinoma.

Structure and Function of Human Carcinoembryonic Antigen-related Cellular Adhesion Molecule 1

Carcinoembryonic Antigen Related Cell Adhesion Molecule 6 Promotes the Proliferation and Migration of Renal Cancer Cells Through the ERK/AKT Signaling Pathway

Structural aspects of CEACAM1 interactions

Clinical and experimental studies regarding the expression and diagnostic value of carcinoembryonic antigen-related cell adhesion molecule 1 in non-small-cell lung cancer

CEACAM expression in an in-vitro prostatitis model

CEACAM1 Is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma

CEACAM1 promotes melanoma metastasis and is involved in the regulation of the EMT associated gene network in melanoma cells

Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells

CEACAM6 promotes tumor migration, invasion, and metastasis in gastric cancer.